IndraLab
Statements
reach
"Our data showed that ET-1 stimulated c-Src-dependent transactivation of the EGFR and PI3K and Akt cascade, and pretreatment with PP1, AG1478, or LY294002 attenuated phosphorylation of MAPKs, including ERK1/2, p38 MAPK, and JNK1/2, suggesting that ET-1-stimulated activation of MAPKs is mediated through c-Src-dependent transactivation of the EGFR and PI3K and Akt cascade."
reach
"The increase in EGFR and HER2 transactivation caused by ET-1 addition to NSCLC cells was inhibited by lapatinib (EGFR and HER2 tyrosine kinase inhibitor (TKI)), gefitinib (EGFR TKI), ZD4054 or BQ-123 (ET A R antagonist), GM6001 (matrix metalloprotease inhibitor), PP2 (Src inhibitor) or Tiron (superoxide scavenger)."